BILIARY-EXCRETION AND PHARMACOKINETICS OF CEFTRIAXONE AFTER CHOLECYSTECTOMY

被引：35

作者：

HAYTON, WL

SCHANDLIK, R

STOECKEL, K

机构：

[1] F HOFFMANN LA ROCHE & CO LTD,DEPT PHARMACEUT RES,124 GRENZACHERSTR,CH-4002 BASEL,SWITZERLAND

[2] REG HOSP,STEYER,AUSTRIA

来源：

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY | 1986年 / 30卷 / 04期

关键词：

D O I：

10.1007/BF00607958

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：445 / 451

页数：7

共 23 条

[1] CEFTRIAXONE - RENAL AND BILIARY-EXCRETION AND EFFECT ON THE COLON MICROFLORA [J].

ARVIDSSON, A ;

ALVAN, G ;

ANGELIN, B ;

BORGA, O ;

NORD, CE .

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1982, 10 (03) :207-215

[2] PHARMACOKINETIC AND MICROBIAL SUSCEPTIBILITY STUDIES OF CEFTRIAXONE [J].

BAUMGARTNER, JD ;

GLAUSER, MP .

EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1983, 2 (05) :501-504

[3] BILIARY-EXCRETION OF CEFTIZOXIME IN HUMANS [J].

BROGARD, JM ;

ARNAUD, JP ;

TIMMLER, R .

CHEMOTHERAPY, 1984, 30 (04) :221-226

[4]

FARQUET C, 1982, SCHWEIZ MED WSCHR, V112, P123

[5]

GIBALDI M, 1982, PHARMACOKINETICS, P143

[6] AGE-ASSOCIATED CHANGES IN CEFTRIAXONE PHARMACOKINETICS [J].

HAYTON, WL ;

STOECKEL, K .

CLINICAL PHARMACOKINETICS, 1986, 11 (01) :76-86

[7]

KEMMERICH B, 1983, J ANTIMICROB CHEMOTH, V19, P27

[8] BILIARY-EXCRETION OF AMOXYCILLIN AND CEFTRIAXONE AFTER INTRAVENOUS ADMINISTRATION IN MAN [J].

MAUDGAL, DP ;

MAXWELL, JD ;

LEES, LJ ;

WILD, RN .

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1982, 14 (02) :213-217

[9] VOLUME OF DISTRIBUTION TERMS FOR A DRUG (CEFTRIAXONE) EXHIBITING CONCENTRATION-DEPENDENT PROTEIN-BINDING .1. THEORETICAL CONSIDERATIONS [J].

MCNAMARA, PJ ;

GIBALDI, M ;

STOECKEL, K .

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1983, 25 (03) :399-405

[10] PHARMACOKINETICS OF CEFTRIAXONE FOLLOWING INTRAVENOUS ADMINISTRATION OF A 3-G DOSE [J].

MCNAMARA, PJ ;

STOECKEL, K ;

ZIEGLER, WH .

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1982, 22 (01) :71-75

← 1 2 3 →